Circulating CD4+CD25highCD127low regulatory T cells are an independent predictor of advanced melanoma

Pigment Cell and Melanoma Research

Volumn 26, Issue 2, 2013, Pages 280-283

  Gambichler, T ^a   Bindsteiner, M ^a   Hoxtermann S ^a   Terras, S ^a   Kreuter, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CD39 ANTIGEN; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADVANCED CANCER; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CD4+ CD25+ CD127- T LYMPHOCYTE; CHEMOLUMINESCENCE; CLINICAL ASSESSMENT; HUMAN; LETTER; LYMPHOCYTE COUNT; MELANOMA; MEMBRANE MARKER; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VITAMIN BLOOD LEVEL;

HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; MELANOCYTES; MELANOMA;

EID: 84874392226     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12055     Document Type: Letter

References (14)

1. Bjoern, J., Brimnes, M.K., Andersen, M.H., Thor Straten, P., and Svane, I.M. (2011). Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. Scand. J. Immunol. 73, 222-233.
2. Correll, A., Tuettenberg, A., Becker, C., and Jonuleit, H. (2010). Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Exp. Dermatol. 19, e213-e221.
3. Facciabene, A., Santoro, S., and Coukos, G. (2012). Know thy enemy: why are tumor-infiltrating regulatory T cells so deleterious? Oncoimmunology. 1, 575-577.
4. Fujii, H., Arakawa, A., Kitoh, A., Miyara, M., Kato, M., Kore-eda, S., Sakaguchi, S., Miyachi, Y., Tanioka, M., and Ono, M. (2011). Perturbations of both nonregulatory and regulatory FOXP3 + T cells in patients with malignant melanoma. Br. J. Dermatol. 164, 1052-1060.
5. Gambichler, T., Tigges, C., Burkert, B., Höxtermann, S., Altmeyer, P., and Kreuter, A. (2010). Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis. Eur. J. Med. Res. 15, 44-46.
6. Gambichler, T., Bindsteiner, M., Höxtermann, S., and Kreuter, A. (2012). Serum 25-hydroxyvitamin D serum levels in a large German cohort of melanoma patients. Br. J. Dermatol. doi: 10.1111/j.1365-2133.2012.11212.x. [Epub ahead of print].
7. Mandapathil, M., Lang, S., Gorelik, E., and Whiteside, T.L. (2009). Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J. Immunol. Methods 346, 55-63.
8. McCarter, M.D., Baumgartner, J., Escobar, G.A., Richter, D., Lewis, K., Robinson, W., Wilson, C., Palmer, B.E., and Gonzalez, R. (2007). Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. Ann. Surg. Oncol. 14, 2854-2860.
9. Morales-Tirado, V., Wichlan, D.G., Leimig, T.E., Street, S.E., Kasow, K.A., and Riberdy, J.M. (2011). 1α, 25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin. Immunol. 138, 212-221.
10. Schmetterer, K.G., Neunkirchner, A., and Pickl, W.F. (2012). Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J. 26, 2253-2276.
11. Schuler, P.J., Schilling, B., Harasymczuk, M., Hoffmann, T.K., Johnson, J., Lang, S., and Whiteside, T.L. (2012). Phenotypic and functional characteristics of CD4(+) CD39(+)FOXP3(+) and CD4(+) CD39(+) FOXP3(neg) T-cell subsets in cancer patients. Eur. J. Immunol. 42, 1876-1885.
12. Smolders, J., Thewissen, M., Peelen, E., Menheere, P., Tervaert, J.W., Damoiseaux, J., and Hupperts, R. (2009). Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 4, e6635.
13. Speeckaert, R., van Geel, N., Vermaelen, K.V., Lambert, J., Van Gele, M., Speeckaert, M.M., and Brochez, L. (2011). Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy. Pigment Cell Melanoma Res. 24, 334-344.
14. + CD25(high)CD127 (low/neg) regulatory T cells. Methods Mol. Biol. 806, 287-299.